156 related articles for article (PubMed ID: 22342921)
1. Ischemia modified albumin and carbonyl protein as potential biomarkers of protein oxidation in hemodialysis.
Albarello K; dos Santos GA; Bochi GV; Sangoi MB; Almeida TC; Paz da Silva JE; Garcia SC; Moresco RN
Clin Biochem; 2012 Apr; 45(6):450-4. PubMed ID: 22342921
[TBL] [Abstract][Full Text] [Related]
2. Differences in ischemia-modified albumin levels between end stage renal disease patients and the normal population.
Turedi S; Cinar O; Yavuz I; Mentese A; Gunduz A; Karahan SC; Topbas M; Cevik E; Yildirim AO; Uzun A; Kaldirim U
J Nephrol; 2010; 23(3):335-40. PubMed ID: 20349416
[TBL] [Abstract][Full Text] [Related]
3. Oxidative modification of albumin in predialysis, hemodialysis, and peritoneal dialysis patients.
Mitrogianni Z; Barbouti A; Galaris D; Siamopoulos KC
Nephron Clin Pract; 2009; 113(3):c234-40. PubMed ID: 19690441
[TBL] [Abstract][Full Text] [Related]
4. Plasma protein carbonylation in chronic uremia.
Pavone B; Sirolli V; Giardinelli A; Bucci S; Forlì F; Di Cesare M; Sacchetta P; Di Pietro N; Pandolfi A; Urbani A; Bonomini M
J Nephrol; 2011; 24(4):453-64. PubMed ID: 21607919
[TBL] [Abstract][Full Text] [Related]
5. The structure and function of oxidized albumin in hemodialysis patients: Its role in elevated oxidative stress via neutrophil burst.
Mera K; Anraku M; Kitamura K; Nakajou K; Maruyama T; Otagiri M
Biochem Biophys Res Commun; 2005 Sep; 334(4):1322-8. PubMed ID: 16054887
[TBL] [Abstract][Full Text] [Related]
6. Association between biomarkers of carbonyl stress with increased systemic inflammatory response in different stages of chronic kidney disease and after renal transplantation.
Aveles PR; Criminácio CR; Gonçalves S; Bignelli AT; Claro LM; Siqueira SS; Nakao LS; Pecoits-Filho R
Nephron Clin Pract; 2010; 116(4):c294-9. PubMed ID: 20639676
[TBL] [Abstract][Full Text] [Related]
7. Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study.
Anraku M; Kitamura K; Shintomo R; Takeuchi K; Ikeda H; Nagano J; Ko T; Mera K; Tomita K; Otagiri M
Clin Biochem; 2008 Oct; 41(14-15):1168-74. PubMed ID: 18692036
[TBL] [Abstract][Full Text] [Related]
8. Dialyzable uremic solutes contribute to enhanced oxidation of serum albumin in regular hemodialysis patients.
Terawaki H; Nakayama K; Matsuyama Y; Nakayama M; Sato T; Hosoya T; Era S; Ito S
Blood Purif; 2007; 25(3):274-9. PubMed ID: 17460395
[TBL] [Abstract][Full Text] [Related]
9. Protein thiol oxidation and lipid peroxidation in patients with uraemia.
Prakash M; Upadhya S; Prabhu R
Scand J Clin Lab Invest; 2004; 64(6):599-604. PubMed ID: 15370466
[TBL] [Abstract][Full Text] [Related]
10. Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients.
Anraku M; Kitamura K; Shinohara A; Adachi M; Suenga A; Maruyama T; Miyanaka K; Miyoshi T; Shiraishi N; Nonoguchi H; Otagiri M; Tomita K
Kidney Int; 2004 Aug; 66(2):841-8. PubMed ID: 15253741
[TBL] [Abstract][Full Text] [Related]
11. Oxidation and carboxy methyl lysine-modification of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients.
Mera K; Anraku M; Kitamura K; Nakajou K; Maruyama T; Tomita K; Otagiri M
Hypertens Res; 2005 Dec; 28(12):973-80. PubMed ID: 16671336
[TBL] [Abstract][Full Text] [Related]
12. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
[TBL] [Abstract][Full Text] [Related]
13. 8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients.
Tarng DC; Huang TP; Wei YH; Liu TY; Chen HW; Wen Chen T; Yang WC
Am J Kidney Dis; 2000 Nov; 36(5):934-44. PubMed ID: 11054349
[TBL] [Abstract][Full Text] [Related]
14. Effects of peritoneal-and hemodialysis on levels of plasma protein and lipid oxidation markers in diabetic patients.
Sozer V; Korkmaz Guntas G; Konukoglu D; Dervisoglu E; Gelisgen R; Tabak O; Kalender B; Uzun H
Minerva Med; 2013 Feb; 104(1):75-84. PubMed ID: 23392540
[TBL] [Abstract][Full Text] [Related]
15. Carbonyl stress in chronic renal failure: the effect of haemodialysis.
Dursun E; Dursun B; Süleymanlar G; Ozben T
Ann Clin Biochem; 2005 Jan; 42(Pt 1):64-6. PubMed ID: 15802036
[TBL] [Abstract][Full Text] [Related]
16. The redox state of albumin and serious cardiovascular incidence in hemodialysis patients.
Terawaki H; Takada Y; Era S; Funakoshi Y; Nakayama K; Nakayama M; Ogura M; Ito S; Hosoya T
Ther Apher Dial; 2010 Oct; 14(5):465-71. PubMed ID: 21175544
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of ischemia modified albumin in overweight/obese postmenopausal women: a potential biomarker of atherosclerotic burden associated with oxidative stress.
Kazanis K; Dalamaga M; Kassi E; Nounopoulos C; Manolis AS; Merantzi G; Jullien G; Dionyssiou-Asteriou A
Maturitas; 2011 Oct; 70(2):182-7. PubMed ID: 21839592
[TBL] [Abstract][Full Text] [Related]
18. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
[TBL] [Abstract][Full Text] [Related]
19. Protein oxidative stress and dyslipidemia in dialysis patients.
Marques de Mattos A; Marino LV; Ovidio PP; Jordão AA; Almeida CC; Chiarello PG
Ther Apher Dial; 2012 Feb; 16(1):68-74. PubMed ID: 22248198
[TBL] [Abstract][Full Text] [Related]
20. The influence of the hemodialysis treatment time under oxidative stress biomarkers in chronic renal failure patients.
Valentini J; Grotto D; Paniz C; Roehrs M; Burg G; Garcia SC
Biomed Pharmacother; 2008; 62(6):378-82. PubMed ID: 18166291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]